Short description
Prenetics is a genetic and diagnostic health testing company that helps to identify health risks with the use of DNA sequencing technology.
Description
Prenetics Global Limited, a genomics-driven health sciences company, engages in revolutionizing prevention, early detection, and treatment in Taiwan, Hong Kong, the United Kingdom, and internationally. It operates through two segments: Prevention and Diagnostics. The company offers CircleDNA, a consumer genetic testing product to offer comprehensive DNA test. It also provides Insighta develops and commercializes multi-cancer early detection technology named Fragma. In addition, the company, through acquisition of ACT Genomics, which is involved in genomic profiling of panels through ACTOnco, ACT HRD, ACTFusion, and ACTDrug. Further, the company offers ACTLiquid Pro, an NGS-based liquid biopsy assay for pan-solid tumors; ACTMonitor which provides realtime monitoring of drug resistance, treatment response, and cancer recurrence; and ACT Risk which manages the cancer risk. Prenetics Global Limited is based in Quarry Bay, Hong Kong.
Last funding
Cannot Access
Sign in for full access
Total funding
$$43214321
Sign in for full access
Location
Quarry Bay, Hong Kong Island, Hong Kong, Asia
Founded on
January 1, 2009
Exited on
May 18, 2022
Went public on
May 18, 2022
Stock symbol
PRE
Non-profit?
No
Acquired?
No
Employees count
251-500
Revenue range
$34056 - 789030
Sign in for full access
Investors
Noaccess, Noway Youcantaccess, Noaccessforu, Noaccessforu, Nopepepe, Noaccessforu, Nopepepe, Cannot Access, Noaccessforu, Nopepepe, Blurry Noaccess, Absolutely Noaccess, Nopepepe, Absolutely Noaccess, Nopepepe, Nopepepe, Blurry Noaccess
Sign in for full access
Founders
Danny Yeung, Lawrence Tzang, Michael M. Yang
Funding rounds count
1
Portfolio organisations count
Noaccessforu, Cannot Access
Sign in for full access